Literature DB >> 34427293

A simplified wall-based model for regional innervation/perfusion mismatch assessed by cardiac 123I-mIBG and rest 99mTc-tetrofosmin SPECT to predict arrhythmic events in ischaemic heart failure.

Derk O Verschure1,2, Edwin Poel1, Mark I Travin3, Milena J Henzlova4, Diwakar Jain5, Arnold F Jacobson6, Hein J Verberne1.   

Abstract

AIMS: Cardiac 123iodine-meta-iodobenzylguanidine (123I-mIBG) single-photon emission computed tomography (SPECT) imaging provides information on regional myocardial innervation. However, the value of the commonly used 17-segment summed defect score (SDS) as a prognostic marker is uncertain. The present study examined whether a simpler regional scoring approach for evaluation of 123I-mIBG SPECT combined with rest 99mTc-tetrofosmin SPECT myocardial perfusion imaging could improve prediction of arrhythmic events (AEs) in patients with ischaemic heart failure (HF). METHODS AND
RESULTS: Five hundred and two ischaemic HF subjects of the ADMIRE-HF study with complete cardiac 123I-mIBG and rest 99mTc-tetrofosmin SPECT studies were included. Both SPECT image sets were read together by two experienced nuclear imagers and scored by consensus. In addition to standard 17-segment scoring, the readers classified walls (i.e. anterior, lateral, inferior, septum and apex) as normal, matched defect, mismatched (innervation defect > perfusion defect), or reverse mismatched (perfusion defect > innervation defect). Cox proportional hazards ratios (HRs) were used to determine if age, body mass index, functional class, left ventricular ejection fraction (LVEF), B-type natriuretic peptide (BNP), norepinephrine, 123I-mIBG SDS, 99mTc-tetrofosmin SDS, innervation/perfusion mismatch SDS, and our simplified visual innervation/perfusion wall classification were associated with occurrence of AEs (i.e. sudden cardiac death, sustained ventricular tachycardia, resuscitated cardiac arrest, appropriate implantable cardioverter-defibrillator therapy). At 2-year median follow-up, 52 subjects (10.4%) had AEs. Subjects with 1 or 2 mismatched walls were twice as likely to have AEs compared with subjects with either 0 or 3-5 mismatched walls (16.3% vs. 8.3%, P = 0.010). Cox regression analyses showed that patients with a visual mismatch in 1-2 walls had an almost two times higher risk of AEs [HR 2.084 (1.109-3.914), P = 0.001]. None of the other innervation, perfusion and mismatch scores using standard 17 segments were associated with AEs. BNP (ng/L) was the only non-imaging parameter associated with AEs.
CONCLUSION: A visual left ventricular wall-level based scoring method identified highest AE risk in ischaemic HF subjects with intermediate levels of innervation/perfusion mismatches. This simple technique for the evaluation of SPECT studies, which are often challenging in HF subjects, seems to be superior to the 17-segment scoring method.
© The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology.

Entities:  

Keywords:  zzm321990 123I-mIBG scintigraphy; arrhythmia; chronic heart failure; innervation/perfusion mismatch

Mesh:

Substances:

Year:  2022        PMID: 34427293      PMCID: PMC9365302          DOI: 10.1093/ehjci/jeab132

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   9.130


  27 in total

1.  Single photon-emission computed tomography.

Authors:  Thomas A Holly; Brian G Abbott; Mouaz Al-Mallah; Dennis A Calnon; Mylan C Cohen; Frank P DiFilippo; Edward P Ficaro; Michael R Freeman; Robert C Hendel; Diwakar Jain; Scott M Leonard; Kenneth J Nichols; Donna M Polk; Prem Soman
Journal:  J Nucl Cardiol       Date:  2010-10       Impact factor: 5.952

2.  EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot).

Authors:  Aldo P Maggioni; Ulf Dahlström; Gerasimos Filippatos; Ovidiu Chioncel; Marisa Crespo Leiro; Jaroslaw Drozdz; Friedrich Fruhwald; Lars Gullestad; Damien Logeart; Gianna Fabbri; Renato Urso; Marco Metra; John Parissis; Hans Persson; Piotr Ponikowski; Mathias Rauchhaus; Adriaan A Voors; Olav Wendelboe Nielsen; Faiez Zannad; Luigi Tavazzi
Journal:  Eur J Heart Fail       Date:  2013-03-28       Impact factor: 15.534

3.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

Authors:  Gust H Bardy; Kerry L Lee; Daniel B Mark; Jeanne E Poole; Douglas L Packer; Robin Boineau; Michael Domanski; Charles Troutman; Jill Anderson; George Johnson; Steven E McNulty; Nancy Clapp-Channing; Linda D Davidson-Ray; Elizabeth S Fraulo; Daniel P Fishbein; Richard M Luceri; John H Ip
Journal:  N Engl J Med       Date:  2005-01-20       Impact factor: 91.245

4.  Cardiac iodine-123 metaiodobenzylguanidine imaging predicts ventricular arrhythmia in heart failure patients receiving an implantable cardioverter-defibrillator for primary prevention.

Authors:  Andrew Marshall; Andrew Cheetham; Robert S George; Mark Mason; Andrew D Kelion
Journal:  Heart       Date:  2012-09       Impact factor: 5.994

5.  Impact of age on myocardial uptake of ¹²³I-mIBG in older adult subjects without coronary heart disease.

Authors:  Arnold F Jacobson; Ji Chen; Liudmilla Verdes; Russell D Folks; Daya N Manatunga; Ernest V Garcia
Journal:  J Nucl Cardiol       Date:  2013-03-13       Impact factor: 5.952

6.  Influence of ejection fraction on the prognostic value of sympathetic innervation imaging with iodine-123 MIBG in heart failure.

Authors:  Amil M Shah; Mikhail Bourgoun; Jagat Narula; Arnold F Jacobson; Scott D Solomon
Journal:  JACC Cardiovasc Imaging       Date:  2012-11

7.  Assessment of 123I-mIBG and 99mTc-tetrofosmin single-photon emission computed tomographic images for the prediction of arrhythmic events in patients with ischemic heart failure: Intermediate severity innervation defects are associated with higher arrhythmic risk.

Authors:  Mark I Travin; Milena J Henzlova; Berthe L F van Eck-Smit; Diwakar Jain; Ignasi Carrió; Russell D Folks; Ernest V Garcia; Arnold F Jacobson; Hein J Verberne
Journal:  J Nucl Cardiol       Date:  2016-01-20       Impact factor: 5.952

8.  Presence of sympathetically denervated but viable myocardium and its electrophysiologic correlates after early revascularised, acute myocardial infarction.

Authors:  Marcus V Simões; Petra Barthel; Ichiro Matsunari; Stephan G Nekolla; Albert Schömig; Markus Schwaiger; Georg Schmidt; Frank M Bengel
Journal:  Eur Heart J       Date:  2004-04       Impact factor: 29.983

9.  123I-mIBG scintigraphy to predict risk for adverse cardiac outcomes in heart failure patients: design of two prospective multicenter international trials.

Authors:  Arnold F Jacobson; John Lombard; Gopa Banerjee; Paolo G Camici
Journal:  J Nucl Cardiol       Date:  2009-01-20       Impact factor: 5.952

10.  Prognostic significance of (123)I-mIBG SPECT myocardial imaging in heart failure: differences between patients with ischaemic and non-ischaemic heart failure.

Authors:  Ian P Clements; Anita A Kelkar; Ernest V Garcia; Javed Butler; Ji Chen; Russell Folks; Arnold F Jacobson
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2015-11-20       Impact factor: 6.875

View more
  2 in total

Review 1.  Cardiac 123I-mIBG Imaging in Heart Failure.

Authors:  Derk O Verschure; Kenichi Nakajima; Hein J Verberne
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-25

2.  Can the promise of radionuclide cardiac innervation imaging be fulfilled?

Authors:  Mark I Travin
Journal:  J Nucl Cardiol       Date:  2022-01-19       Impact factor: 5.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.